相关实验视频
Updated: Jan 13, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
黑色素瘤生存的危险因素:DGCR8作为年轻患者死亡率的预测因素
Fabiola Schafer1, Enrique Bellolio2, Tatiana Sepúlveda2
1Department of Medical Specialties, School of Medicine, Universidad de La Frontera, Temuco, Chile. fdschafe@gmail.com.
Acta dermato-venereologica
|January 9, 2026
概括
微RNA处理酶DGCR8可以预测黑色素瘤患者的死亡风险. 积极的DGCR8表达表明死亡风险较高,特别是在年轻的患者中,有助于对高风险个体进行分层.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 微RNA处理酶Dicer和DGCR8在黑色素瘤中失调.
- 黑色素瘤的进展和患者的存活率受到微RNA通路的影响.
研究的目的:
- 调查DGCR8和Dicer作为黑色素瘤死亡率的潜在风险因素.
- 评估这些酶在分层患者风险中的有用性.
主要方法:
- 74名黑色素瘤患者的回顾性队列研究.
- 免疫组织化学用于评估DGCR8和Dicer表达 (%IRC).
- 基于80%的IRC切线的二元表达式 (负/正).
主要成果:
- 阶段III-IV黑色素瘤患者的5年生存率为18.5%.
- 阳性DGCR8表达是年龄≤42岁的患者死亡率的显著预测因素 (HR=14.3,p=0.024).
- 多变量分析发现阳性DGCR8和年轻年龄 (≤42) 与III-IV阶段黑色素瘤的生存率较低有关.
结论:
- 对于黑色素瘤患者的死亡率,DGCR8表达可能成为一种新的生物标志物.
- DGCR8阳性可以帮助识别高风险黑色素瘤患者,特别是年轻人.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K

